Focusing on modulating the extremes of amino acid metabolism, we use novel engineered human enzymes
Location: United States, Texas, Austin
Employees: 51-200
Founded date: 2013
Mentions in press and media 2
| Date | Title | Description |
| 04.11.2021 | Aeglea BioTherapeutics Reports Third Quarter 2021 Financial Results and Corporate Highlights - Form 8-K | Aeglea BioTherapeutics Reports Third Quarter 2021 Financial Results and Corporate Highlights PEACE baseline data at upcoming medical meeting underscore disease severity and significant limitations of current standard of care in controlling ... |
| 03.02.2021 | Aeglea BioTherapeutics Announces Transition of Chief Financial Officer |